MODD (Modular Medical) Net Profit

Corporate emblem and logo of Modular Medical (MODD)

Modular Medical relies on external contractors for applicator assembly, which creates logistical risks. The firm is currently spending reserves on certification; consequently, the company's income and expenditure balance reflects current dynamics where the -0.03 indicator points to the profit status. The prospects for Modular Medical (MODD) depend on FDA approval and the adoption of new pumps by patients with diabetes.

MODD: Modular Medical Net Profit 07/04/2022 - 10/29/2026

Financial and market metric breakdowns for modular-medical.com (MODD)

- current quotes and average value forecast:
Market Chart Modular Medical, Inc.|MODD - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization MODD|MODD - Total Company Value
- book capitalization data:
Net Assets per Single Share Modular Medical|MODD - Book Capitalization|Market Capitalization to Book Value modular-medical.com|MODD - Cumulative Company Assets
- debt and liquidity details:
Aggregate Debt to Equity Modular Medical|MODD - Long-Term Debt to Capital|Current Liabilities to Capital Modular Medical, Inc.|MODD - Company Aggregate Debts|Debt to Book Value Ratio MODD|MODD - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Modular Medical|Quick Liquidity Indicator modular-medical.com
- earnings and valuation multiples information:
MODD - Net Profit
Fundamental valuation:Modular Med
Product sample of Modular Medical

For Modular Medical (MODD), this indicator serves as a tool to verify market demand for innovative medical solutions amidst fierce competition. By analyzing the company's net income, investors assess the remaining funds after all expenses, which directly reflects the efficiency of scaling insulin pump sales and monetizing consumables through the US insurance reimbursement system.

Key competitors

BSX - Net Financial Result|EW (Edwards Lifesciences) - Net Profit|Net Profit resmed.com|Company Net Income Insulet (PODD)|Company Net Income ZBH (Zimmer Biomet Holdings)|Net Profit COO (CooperVision)|Net Financial Result Align Corp (ALGN)|GMED: Net Income|Profit After Tax TMDX|ATEC: Net Profit|Company Net Income CryoLife (AORT)|ENOV (DJO Global) - Net Profit|Company Profit IART (Integra LifeSciences Inc.)|Net Income ESTA (Establishment Labs)|BBNX (betabionics.com) - Final Profit|Company Net Income IRADIMED IRMD|EMBC - Net Income|Tandem Diabetes - Net Profit|Company Net Income Axogen Surgical|SIBN: Net Profit|Company Profit OFIX|BVS (Bioventus) - Net Profit|OrthoPediatrics Inc. (KIDS) - Net Financial Result|Net Profit TMCI|Net Income Strata Medical SRTA|Net Profit CARL (Carlsmed Inc)|Net Profit rxsight.com RXST|CLPT - Company Net Income|STXS: Company Net Income|STIM (NeuroStar) - Net Income|Sight Sciences Inc - Final Profit|OBIO (Orchestra BioMed) - Net Profit|Company Net Income Anika ANIK|Company Net Income InspireMD (NSPR)|zhjmedical.com (ZJYL) - Annual Net Income|Vivani Medical - Net Income|Net Profit Xtant Medical Holdings, Inc. XTNT|NeuroOne Medical Technologies - Net Profit|Net Financial Result myomo.com MYO|Envoy Medical (COCH) - Company Net Income|Profit After Tax VVOS (Vivos Therapeutics Inc.)|Company Net Income enVVeno|Net Income SINTX Technologies (SINT)|Net Profit TNON|LFWD - Company Net Income|Company Net Income Autonomix Medical AMIX|IVF: Company Profit|BBLG: Net Income|Axonics, Inc - Profit After Payment of Taxes|BIOLASE, Inc. (BIOL) - Company Net Income|Net Income Dynatronics|Company Net Income Paragon 28 Inc.|Company Net Income INVO Bio INVO